Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Abdominal Hysterectomy
9%
Adenocarcinoma
11%
Assisted Reproductive Technology
22%
Autofluorescence
16%
Biological Marker
21%
Biopsy
23%
Birth Weight
11%
Bleeding
12%
Body Mass Index
10%
Brain Imaging
9%
Breast Cancer
18%
CA-125
8%
Cancer
26%
Cancer Cell
11%
Cancer Diagnosis
15%
Carcinogenesis
15%
Carcinoma
10%
Cervical Cancer
49%
Cervical Intraepithelial Neoplasia
13%
Cervix
31%
Childbirth
18%
Chorionic Gonadotropin
14%
Cisplatin
8%
Colon
12%
Colon Cancer
12%
Colony Stimulating Factor 1
9%
Colposcopy
8%
COVID-19
14%
Cytotechnology
10%
Diagnosis
22%
Disease
56%
Dysplasia
10%
Endometrial Cancer
11%
Endometriosis
31%
Endometrium
10%
Endometrium Carcinoma
11%
Endoscope
26%
Endoscopy
9%
Ex Vivo
22%
Extracellular Matrix
10%
Fallopian Tube
26%
Female Genital Tract Cancer
20%
Fetus Growth
8%
Folic Acid
9%
Gene Linkage
9%
Gestational Trophoblastic Disease
14%
Gynecological Oncology
25%
Hazard Ratio
16%
Health Care
8%
Hysterectomy
11%
In Vitro
22%
Infection
14%
Insulin Release
25%
Intrauterine Growth Retardation
26%
Krukenberg Tumor
16%
Laser Induced Fluorescence
18%
Laser Induced Fluorescence Spectroscopy
9%
Magnetic Resonance Imaging
9%
Malignant Neoplasm
66%
Menstrual Cycle
16%
Metastatic Carcinoma
22%
Methotrexate
11%
Multiphoton Microscopy
11%
Neoplasm
40%
Noradrenalin
8%
Nurse
10%
Obstetrics
13%
Odds Ratio
12%
Optical Coherence Tomography
46%
Ovarian Cancer
100%
Ovariectomy
14%
Pancreatic Islet
17%
Papillomavirus Infection
10%
Patient Referral
9%
Pelvic Exenteration
8%
Pelvis
30%
Placental Insufficiency
14%
Pregnancy
14%
Premature Labor
22%
Prevalence
8%
Prospective Cohort Study
23%
Proto Oncogene
9%
Radiation Therapy
18%
Radical Hysterectomy
16%
Recurrent Disease
21%
Reoperation
11%
Reproductive Medicine
8%
Reproductive Public Health
9%
Retroperitoneal Lymph Node Dissection
8%
Serous Carcinoma
10%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Spectrofluorometry
11%
Squamous Cell Carcinoma
21%
Surgeon
8%
Surgery
19%
Symptom
13%
Trophoblastic Disease
9%
Vascularity
11%
Wart Virus
14%
Women's Health
10%
Keyphrases
Adverse Effects
5%
Anti-Mllerian Hormone
9%
Autofluorescence
7%
Bragg
6%
Cervical Cancer
27%
Cervical Carcinoma
8%
Cervical Intraepithelial Neoplasia
9%
Chemotherapy
15%
Cisplatin
13%
Condyloma Acuminatum
9%
Confidence Interval
27%
Diethylstilbestrol
6%
Dual-modal Imaging
6%
Early Invasive Strategy
6%
Endogenous Contrast
6%
Endogenous Fluorescence
7%
Endometrial Cancer
9%
Endometriosis
7%
Endometrium
10%
Endoscope
9%
Epithelial Ovarian Cancer
6%
Fallopian Tube
5%
Female Firefighters
12%
Fetal Sheep
9%
Fetus
12%
Firefighters
5%
Fluorescence Spectroscopy
10%
Gestational Trophoblastic Disease
6%
Group Studies
15%
Gynecologic Oncology Group
18%
Gynecological Cancer
12%
Hazard Ratio
6%
High numerical Aperture Objective
6%
High Risk
5%
High Selectivity
6%
High-risk Human Papillomavirus (HR-HPV)
6%
Histology
7%
Hologram
6%
Hormone Levels
10%
Human Ovarian Cancer
6%
Hysterectomy
8%
Image Contrast
6%
Image Information
6%
Image Processing
6%
Imaging Instrument
6%
Imaging Techniques
6%
Infertility
22%
Insulin Secretion
6%
Intrauterine Growth
8%
Islet
6%
Laparotomy
7%
Laser-induced Fluorescence
6%
Minimally Invasive
5%
Mobile Platform
6%
Mouse Model
13%
Multicolor Fluorescence Imaging
9%
Multiphoton Imaging
6%
Multiphoton Microscopy
8%
Neovagina
6%
Nurses' Health Study
8%
Nutritional Status
6%
OCT Probe
6%
Oncologic
6%
Oophorectomy
6%
Optical Coherence Tomography
27%
Ovarian Cancer
23%
Ovarian Cancer Screening
9%
Ovarian Tissue
9%
Papillomavirus Infections
5%
Pelvic Exenteration
6%
Phase II Study
7%
Post-acute Sequelae of COVID-19 (PASC)
6%
Pregnancy Outcome
9%
Preterm Birth
6%
Prospective Cohort Study
6%
Q-switched Alexandrite Laser
6%
Radiation Therapy
6%
Radical Hysterectomy
8%
Registry Linkage
6%
Selective Intrauterine Growth Restriction (sIUGR)
9%
Squamous Cell Carcinoma of the Cervix
7%
Tissue Imaging
6%
Tissue Model
6%
Tryptophan Fluorescence
6%
Tubal Ligation
6%
Tumor
10%
Ultrasound Tomography
6%
Verruca Plantaris
6%
Viable Tissue
6%
Vigilin
6%
Volume Hologram
6%
Volume Holographic Imaging
9%